Doxazosin is a quinazoline-class alpha-1 adrenergic receptor antagonist primarily indicated for the treatment of hypertension and benign prostatic hyperplasia. Pharmaceutical laboratories utilize this… Read more
![Chemical structure of (2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-nitrosopiperazin-1-yl)methanone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F23-Dihydrobenzob14dioxin-2-yl4-nitrosopiperazin-1-ylmethanone.png&w=3840&q=75)

























![Chemical structure of Ethyl benzo[b][1,4]dioxine-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F63881-51-6-Ethyl-benzob14dioxine-2-carboxylate.png&w=3840&q=75)
![Chemical structure of Methyl 2,3-dihydrobenzo[b][1,4]dioxine-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3663-79-4-Methyl-23-dihydrobenzob14dioxine-2-carboxylate.png&w=3840&q=75)
![Chemical structure of N-(2-((4-Amino-6,7-dimethoxyquinazolin-2-yl)amino)ethyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F740066-32-4-N-2-4-Amino-67-dimethoxyquinazolin-2-ylaminoethyl-23-dihydrobenzob14dioxine-2-carboxamide.png&w=3840&q=75)

Doxazosin is a quinazoline-class alpha-1 adrenergic receptor antagonist primarily indicated for the treatment of hypertension and benign prostatic hyperplasia. Pharmaceutical laboratories utilize this category of reference standards to ensure rigorous quality control and regulatory compliance throughout the drug development lifecycle. The collection includes the parent active ingredient alongside its pharmacopeial and non-pharmacopeial impurities, which are essential for conducting comprehensive impurity profiling. These materials allow analysts to identify and quantify degradation products—such as those formed through hydrolysis, oxidation, or photolysis—and synthetic by-products. Additionally, stable isotope labelled compounds are available to serve as precise internal standards for mass spectrometry applications. By incorporating these materials into analytical testing, researchers can ensure accurate method validation and reliable quantification, supporting the maintenance of safety and efficacy standards throughout the assessment of pharmaceutical formulations.